Richard Gower

3.1k total citations
35 papers, 896 citations indexed

About

Richard Gower is a scholar working on Genetics, Rheumatology and Hematology. According to data from OpenAlex, Richard Gower has authored 35 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 9 papers in Rheumatology and 9 papers in Hematology. Recurrent topics in Richard Gower's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (26 papers), Urticaria and Related Conditions (8 papers) and Hemophilia Treatment and Research (8 papers). Richard Gower is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (26 papers), Urticaria and Related Conditions (8 papers) and Hemophilia Treatment and Research (8 papers). Richard Gower collaborates with scholars based in United States, Germany and United Kingdom. Richard Gower's co-authors include Marc A. Riedl, William R. Lumry, Aleena Banerji, Peter F. Köhler, Henry N. Claman, W. Mitchell Sams, E. George Thorne, Jonathan A. Bernstein, Timothy Craig and Joshua Jacobs and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Journal of Investigative Dermatology.

In The Last Decade

Richard Gower

34 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Gower United States 18 519 402 257 170 150 35 896
Samantha Griffini Italy 14 308 0.6× 408 1.0× 219 0.9× 359 2.1× 55 0.4× 26 923
Martina Burlando Italy 16 98 0.2× 252 0.6× 227 0.9× 460 2.7× 357 2.4× 96 859
Christina Dickson United States 10 177 0.3× 701 1.7× 90 0.4× 221 1.3× 58 0.4× 13 931
Giovanni Lo Scocco Italy 12 28 0.1× 272 0.7× 25 0.1× 148 0.9× 253 1.7× 23 702
Masayuki Miyata Japan 14 51 0.1× 172 0.4× 54 0.2× 85 0.5× 25 0.2× 43 547
Takaharu Ikeda Japan 13 43 0.1× 315 0.8× 75 0.3× 155 0.9× 50 0.3× 51 500
P H Schur United States 9 156 0.3× 219 0.5× 104 0.4× 218 1.3× 5 0.0× 12 490
José‐Tomás Navarro Spain 17 305 0.6× 48 0.1× 571 2.2× 66 0.4× 35 0.2× 85 964
Abby Van Voorhees United States 10 31 0.1× 478 1.2× 181 0.7× 612 3.6× 247 1.6× 25 943
Sigrid Lundberg Sweden 12 38 0.1× 61 0.2× 124 0.5× 112 0.7× 6 0.0× 31 554

Countries citing papers authored by Richard Gower

Since Specialization
Citations

This map shows the geographic impact of Richard Gower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Gower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Gower more than expected).

Fields of papers citing papers by Richard Gower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Gower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Gower. The network helps show where Richard Gower may publish in the future.

Co-authorship network of co-authors of Richard Gower

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Gower. A scholar is included among the top collaborators of Richard Gower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Gower. Richard Gower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eichenfield, Lawrence F., Richard Gower, Jinhua Xu, et al.. (2023). Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study. American Journal of Clinical Dermatology. 24(4). 623–635. 24 indexed citations
2.
Meadows, J. Allen, John Anderson, & Richard Gower. (2023). Challenges in the management of hereditary angioedema in urban and rural settings. Annals of Allergy Asthma & Immunology. 130(6). 760–767.e3. 6 indexed citations
3.
Wedner, H. James, Emel Aygören‐Pürsün, Jonathan A. Bernstein, et al.. (2021). Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2). The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2305–2314.e4. 35 indexed citations
4.
5.
Gower, Richard, et al.. (2021). Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedema. Allergy Asthma and Clinical Immunology. 17(1). 100–100. 4 indexed citations
6.
Riedl, Marc A., Aleena Banerji, & Richard Gower. (2020). Current medical management of hereditary angioedema. Annals of Allergy Asthma & Immunology. 126(3). 264–272. 30 indexed citations
7.
Schlessinger, Joel, Richard Gower, John Su, et al.. (2020). Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1). American Journal of Clinical Dermatology. 21(2). 275–284. 66 indexed citations
8.
Craig, Timothy, Paula J. Busse, Richard Gower, et al.. (2018). Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency. Annals of Allergy Asthma & Immunology. 121(6). 673–679. 22 indexed citations
9.
Lumry, William R., Timothy Craig, Bruce L. Zuraw, et al.. (2018). Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 6(5). 1733–1741.e3. 67 indexed citations
10.
Lumry, William R., et al.. (2015). Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema. Pediatric Allergy and Immunology. 26(7). 674–680. 18 indexed citations
11.
Riedl, Marc A., Aleena Banerji, & Richard Gower. (2014). Current Medical Management of Hereditary Angioedema: Follow-up Survey of US Physicians. The Journal of Allergy and Clinical Immunology In Practice. 3(2). 220–227. 18 indexed citations
12.
Bernstein, Jonathan A., Michael Manning, Henry Li, et al.. (2013). Escalating Doses of C1 Esterase Inhibitor (CINRYZE) for Prophylaxis in Patients With Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 2(1). 77–84.e1. 39 indexed citations
13.
Sánchez‐Borges, Mario, Riccardo Asero, Ignacio J. Ansotegui, et al.. (2012). Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective. SHILAP Revista de lepidopterología. 5(11). 125–147. 137 indexed citations
14.
Gower, Richard, William R. Lumry, Mark Davis‐Lorton, Douglas Johnston, & Paula J. Busse. (2012). Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations. Allergy and Asthma Proceedings. 33(3). 235–240. 13 indexed citations
15.
Riedl, Marc A., Richard Gower, & Carole A. Chrvala. (2011). Current medical management of hereditary angioedema: results from a large survey of US physicians. Annals of Allergy Asthma & Immunology. 106(4). 316–322.e4. 34 indexed citations
16.
Gower, Richard, Paula J. Busse, Emel Aygören‐Pürsün, et al.. (2011). Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies. World Allergy Organization Journal. 4(2). S9–S21. 35 indexed citations
17.
Craig, Timothy, Marc A. Riedl, Mark S. Dykewicz, et al.. (2009). When is prophylaxis for hereditary angioedema necessary?. Annals of Allergy Asthma & Immunology. 102(5). 366–372. 60 indexed citations
18.
19.
Pearlman, David S., Peter S. Creticos, Kathy Lampl, et al.. (2005). Once-daily ciclesonide is effective and well-tolerated in adult and adolescent patients with mild-to-moderate asthma. Journal of Allergy and Clinical Immunology. 115(2). S212–S212. 2 indexed citations
20.
Schmier, Jordana K., Nancy Kline Leidy, & Richard Gower. (2003). Reduction in Oral Corticosteroid Use with Mometasone Furoate Dry Powder Inhaler Improves Health-Related Quality of Life in Patients with Severe Persistent Asthma. Journal of Asthma. 40(4). 383–393. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samantha Griffini Breakdown of academic impact, for papers by Martina Burlando Breakdown of academic impact, for papers by Christina Dickson Breakdown of academic impact, for papers by Giovanni Lo Scocco Breakdown of academic impact, for papers by Masayuki Miyata Breakdown of academic impact, for papers by Takaharu Ikeda Breakdown of academic impact, for papers by P H Schur Breakdown of academic impact, for papers by José‐Tomás Navarro Breakdown of academic impact, for papers by Abby Van Voorhees Breakdown of academic impact, for papers by Sigrid Lundberg
Rankless by CCL
2026